Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERENUMAB vs ERIBULIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERENUMAB vs ERIBULIN: Safety Overview

Metric ERENUMAB ERIBULIN
Total FAERS Reports 1,183 5,055
Deaths Reported 363 793
Death Rate 30.7% 15.7%
Hospitalizations 498 2,642
Average Patient Age 45.6 yrs 57.3 yrs
% Female Patients 93.4% 93.0%
FDA Approval Date N/A Apr 5, 2024
Manufacturer Amgen Inc Gland Pharma Limited
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status N/A Prescription